GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5330 BIM 187Summary: Bombesin/GRP receptor agonist
- B5331 BIM 189Summary: Bombesin antagonist
- B5352 [Des-octanoyl]-Ghrelin (rat)Summary: Non-acylated, major circulating isoform of ghrelin
- B5358 Gastrin I (human)Summary: selective CCK2 receptor agonist
- B5359 Apelin-17 (human, bovine)Summary: Endogenous apelin receptor agonist
- B5360 Galanin (porcine)Summary: Endogenous porcine galanin receptor agonist
- B5361 Neuropeptide W-23 (human)Summary: Endogenous peptide agonist of Neuropeptide B/Neuropeptide W receptors NPBW1 and NPBW2
- B5362 α-CGRP (human)Summary: Endogenous calcitonin gene-related peptide receptor (CGRP) agonist
- B5363 [Nle4,D-Phe7]-α-MSHSummary: agonist at melanocortin receptors
- B5364 HOE 140Summary: Potent and selective bradykinin B2 receptor antagonist